SPRINGWORKS THERAPEUTICS, INC. Earnings Per Share (Diluted)
SPRINGWORKS THERAPEUTICS, INC. reported Earnings Per Share (Diluted) of -$1.11 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-05-09
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-03-31 was -$1.11.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2024-09-30 was -$0.72.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2024-06-30 was -$0.54.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2024-03-31 was -$1.18.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was -$3.48.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$5.15.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$5.21.
- SPRINGWORKS THERAPEUTICS, INC. earnings per share, diluted for fiscal 2021 was -$3.59.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$1.11 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | -$3.48 10-K · filed 2025-02-20 | |||
| 2024-09-30 | -$0.72 10-Q · filed 2024-11-12 | -$2.44 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | -$0.54 10-Q · filed 2024-08-07 | -$1.72 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | -$1.18 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | -$5.15 10-K · filed 2025-02-20 | |||
| 2023-09-30 | -$1.27 10-Q · filed 2024-11-12 | -$3.70 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$1.25 10-Q · filed 2024-08-07 | -$2.43 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$1.18 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$5.21 10-K · filed 2025-02-20 | |||
| 2022-09-30 | -$1.37 10-Q · filed 2023-11-02 | -$4.04 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$1.41 10-Q · filed 2023-08-02 | -$2.67 10-Q · filed 2023-08-02 | ||
| 2021-12-31 | -$3.59 10-K · filed 2024-02-27 | |||
| 2020-12-31 | -$1.05 10-K · filed 2023-02-28 | |||
| 2019-12-31 | -$3.81 derived: net income ÷ weighted average shares · filed 2022-02-24 |